Ligand Pharma (LGND) PT Raised to $252 at RBC Capital

April 28, 2026 5:06 AM

RBC Capital analyst Douglas Miehm raised the price target on Ligand Pharma (NASDAQ: LGND) to $252.00 (from $235.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found